Clinical Trials Logo

Medulloblastoma, Childhood clinical trials

View clinical trials related to Medulloblastoma, Childhood.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04860934 Completed - Childhood Cancer Clinical Trials

Dual Task Training On Children With Ataxia After Medulloblastoma Resection

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. With the goal of, complete resection, major complications during tumor removal are usually caused by damage to the brain stem and injury to the lower cranial nerves.It has been reported that those children present Ataxia after resection. So the purpose of this study is to investigate the effectiveness of using a selected dual-task- training program to improve postural stability in those Children.

NCT ID: NCT04528316 Completed - Clinical trials for Medulloblastoma, Childhood

Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor

Start date: August 6, 2020
Phase: N/A
Study type: Interventional

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. It has been reported that those children fall frequently so the purpose of this study is to investigate the effectiveness of balance and coordination training in these Children.

NCT ID: NCT02238899 Completed - Ependymoma Clinical Trials

Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma

Start date: January 2011
Phase: N/A
Study type: Observational

The Register is based on the study HIT 2000 that recruited patients until 31.12.2011. All german patients with intracranial medulloblastoma, CNS-PNET, ependymoma can be included in the register. Object of the register is to maintain the quality of diagnostic standard by using of central review (Neuroradiology, Pathology, and cranio spinal fluid (CSF) cytology). Furthermore, the register should enable to continue the collection of epidemiologic data and biological material (tumor material, CSF, and blood) for associated studies.